Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Status:
Terminated
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This is a multicenter Phase 2 randomized parallel-group study to determine the effect of
Telintra treatment on severe chronic neutropenia. Patients will be randomized to Telintra or
enter an observation period with an option to crossover to Telintra treatment in a 1:1
allocation.